Observing HeRO Graft and Super HeRO in dialysis patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is tracking how well the HeRO Graft and Super HeRO work for people on dialysis. If you already have one of these devices, joining helps doctors see how it performs over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have end-stage kidney disease and are on hemodialysis.
- You have already received a HeRO Graft or Super HeRO System for your dialysis.
- You cannot have had a HeRO device replaced or fixed before.
- You must not have an active infection near the device site or in your bloodstream.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This study follows people with kidney failure who need dialysis access, when they receive an AV (artery-to-vein) access graft made from a processed donor artery. It’s meant to track safety and how well the new graft performs in real-world care.
This trial studies a procedure to open up blocked or narrowed areas in the plastic tube (graft) used for dialysis. It aims to see if the procedure works well and if it is cost-effective for patients who have trouble completing dialysis because of graft issues.
This study tests a new type of graft (aXess) for dialysis access in people with kidney failure who cannot get a fistula. The graft is placed in the arm to help with blood flow during dialysis.
This study tests whether a special ultrasound implant (EchoMark) helps a new dialysis fistula mature properly. It involves people with advanced kidney disease who are starting or already on dialysis and are having a fistula created in the upper arm.
This is an observational registry that collects information from people with kidney disease who are seen by the kidney team at Royal London Hospital. It helps researchers study heart and kidney health over time without needing extra tests or visits.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.